;
OICR News
‘Ultrarapid’ genomic testing could shift paradigm for cancer treatment
An OICR initiative has reduced the turnaround time for whole genome and transcriptome sequencing in pancreatic cancer studies from 45 to 14 days. Every day matters in the race against cancer. Patients need access to the best, most complete information about their cancer so they can receive the best possible treatments. And the earlier they […]
Read the story
Featured Story